Federal Act
on Medicinal Products and Medical Devices
(Therapeutic Products Act, TPA)


Open article in different language:  DE  |  FR  |  IT
Art. 21 Restrictions on export and foreign trade

1 The ex­port of medi­cin­al products and their for­eign trade from Switzer­land shall be pro­hib­ited if:

a.
they are pro­hib­ited in the tar­get coun­try;
b.76
cir­cum­stances sug­gest that they are in­ten­ded for il­leg­al pur­poses; or
c.77
it is deemed that they are in­ten­ded for cap­it­al pun­ish­ment.

1bis The Fed­er­al Coun­cil shall reg­u­late the re­quire­ments for the ex­port and for­eign trade of medi­cin­al products which could be used for cap­it­al pun­ish­ment. It shall take ac­count of the EU pro­vi­sions.78

2 The Fed­er­al Coun­cil may stip­u­late that in par­tic­u­lar cases the ex­port of medi­cin­al products which are not au­thor­ised in Switzer­land or in the tar­get coun­try is pro­hib­ited by the Agency or sub­ject to re­stric­tions.

3 The Agency shall draw up a list of medi­cin­al products for which ex­port shall be re­stric­ted or pro­hib­ited.

4 In par­tic­u­lar cases, it may grant ex­emp­tions from ex­port re­stric­tions or bans, in par­tic­u­lar if the au­thor­ity of the tar­get coun­try agrees to the im­port.

76 Amended by No I of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).

77 In­ser­ted by No I of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).

78 In­ser­ted by No I of the FA of 18 March 2016, in force since 1 Jan. 2019 (AS 2017 2745, 2018 3575; BBl 2013 1).

Diese Seite ist durch reCAPTCHA geschützt und die Google Datenschutzrichtlinie und Nutzungsbedingungen gelten.

Feedback
Laden